期刊文献+

微渗析技术研究克拉霉素亚微乳剂相分布 被引量:1

Investigation of phase distribution of clarithromycin submicron emulsion by microdialysis technique
下载PDF
导出
摘要 目的:利用微渗析技术研究克拉霉素(clarithromycin,CLA)亚微乳剂相分布,考察离子对增溶剂及NaOH用量对乳剂相分布的影响。方法:以维生素E琥珀酸酯(tocopherol succinate,TS)、油酸为离子对增溶剂,制备CLA亚微乳剂;浓差法测定探针回收率与传递率,以亚微乳剂为渗析介质,用反相渗析法测定回收率。结果:反相渗析法测得回收率为86.2%;90%以上的药物分布于乳剂油相中。结论:微渗析技术可以用于测定乳剂的相分布,TS促进CLA于乳剂油相分布的能力更强,且对体系pH值变化较不敏感。 Objective:To investigate the phase distribution of clarithromycin submicron emulsion by microdialysis technique,and observe the effects of ion pairing reagents and NaOH amount on the phase distribution of the emulsion.Methods:Clarithromycin parenteral emulsion was prepared using tocopherol succinate and oleic acid as ion pairing reagents.Zero net flux methods were used to assess the recovery and delivery of the probe.Retrodialysis method was employed to determine the recovery using submicron emulsion as the surrounding medium.Results:The recovery of the microdialysis probe was 86.2%,and more than 90% of clarithromycin distributed into the oil phase of the emulsion.Conclusion:Microdialysis technique could be utilized to investigate the phase distribution of clarithromycin submicron emulsion.Tocopherol succinate facilitated the distribution of clarithromycin into the oil phase of the emulsion,and the capacity of which was stronger and less sensitive to the pH value than that of oleic acid.
出处 《中国新药杂志》 CAS CSCD 北大核心 2008年第14期1247-1249,共3页 Chinese Journal of New Drugs
关键词 微渗析 克拉霉素 亚微乳剂 相分布 维生素E琥珀酸酯 microdialysis,clarithromycin,submicron emulsion,phase distribution,tocopherol succinate
  • 相关文献

参考文献10

  • 1CANNON JB, WILLIAMS NA,PAPP KJ. Reduction of pain on intravenous infusion with bile salt formulations for a macrolide antibiotic [ J ]. Int J Pharm, 1995,114 ( 1 ) :65 - 74.
  • 2LOVELL MW, JOHNSON HW, HUI HW,et al. Less-painful emulsion formulations for intravenous administration of clarithromycin [ J ].Int J Pharm, 1994,109 ( 1 ) :45 - 57.
  • 3JENSEN SM,HANSEN HS,JOHANSEN T,et al. In vivo and in vitro microdialysis sampling of free fatty acids [ J ]. J Pharm Biomed Anal ,2007,43 (5) : 1751 - 1756.
  • 4MICHALOWSKI CB, GUTERRES SS,DALLA-COSTA T. Microdialysis for evaluating the entrapment and release of a lipophilic drug from nanoparticles [ J]. J Pharm Biomed Anal, 2004,35 (5) :1093 - 1100.
  • 5CHAURASIA CS, MULLER M, BASHAW ED,et al. AAPS-FDA workshop white paper: microdialysis principles,application and regulatory perspectives[J]. Pharm Res,2007,24 (5) :1014 -1025.
  • 6何海冰,唐星,崔福德.血液微渗析技术研究酮洛芬在大鼠体内的药代动力学[J].药学学报,2006,41(5):452-456. 被引量:3
  • 7HOCHT C, OPEZZO JAW,TAIRA CA. Applicability of reverse microdialysis in pharmacological and toxicological studies[ J]. J Pharmacol Toxicol Methods,2007,55 ( 1 ) :3 - 15.
  • 8CHEN KC. Effects of tissue trauma on the characteristics of microdialysis zero-net-flux method sampling neurotransmitters [ J ]. J Theor Biol,2006,238 (4) :863 - 881.
  • 9丁平田,魏刚,李虹,郑俊民.浓差法用于微渗析回收率的测定[J].中国药学杂志,2001,36(10):690-694. 被引量:12
  • 10隗慧林,陈沄,徐兰芳,郑家润.反向透析法用于体内经皮吸收微透析探针回收率的测定[J].中国新药杂志,2007,16(13):1024-1027. 被引量:4

二级参考文献11

  • 1Ding P T,Biomed Chromatogr,2000年,14卷,1期,141页
  • 2KREILGAARD M. Assessment of cutaneous drug delivery using microdialysis[J]. Adv Drug Deliv Rev, 2002, 54 ( Suppl 1 ) : $99 - S121.
  • 3MULLER M. Microdialysis[J]. BMJ, 2002, 324(9):588-591.
  • 4STAGNI G, ALl ME, WENG D. Pharmacokinetics of acyclovir in rabbit skin after Ⅳ-bolus, ointment, and iontophoretic administrations[J].Int J Pharm,2004,274(1/2 ) :201 -211.
  • 5STENKEN JA. Methods and issues in microdialysis calibration [J]. Anal Chim Acta, 1999, 379(3) :337 -358.
  • 6ZHAO YP, LIANG XZ, LUNTE CE. Comparison of recovery and delivery in vitro for calibration of microdialysis probes [ J ]. Anal Chim Acta, 1995, 316(3) :403 -410.
  • 7SONG Y, LUNTE CE. Calibration methods for microdialysis sampiing in vivo: muscle and adipose tissue [J]. Anal Chim Acta, 1999, 400(1/3) : 143 - 152.
  • 8ABRAHAMSSON P, WINSO O. An assessment of calibration and performance of the microdialysis system [ J ]. J Pharm Biomed Anal,2005, 39(3/4) :730 -734.
  • 9丁平田,徐晖,卞生杰,郑俊民.以经皮微渗析技术研究奥旦西酮的大鼠在体经皮吸收[J].药学学报,2000,35(4):305-308. 被引量:11
  • 10丁平田,徐晖,郑俊民.微渗析技术在药代动力学和药物代谢研究中的应用[J].药学学报,2002,37(4):316-320. 被引量:16

共引文献16

同被引文献19

  • 1陆彬.纳米乳与亚微乳给药系统[J].中国药师,2004,7(10):759-761. 被引量:22
  • 2岳鹏飞,袁海龙,杨明,游荣辉,朱卫丰,肖小河.葛根素亚微乳的制备及表征[J].药学学报,2007,42(6):649-655. 被引量:12
  • 3游荣辉,丛龙波,袁海龙.静脉亚微乳研究进展及其在现代中药研究中的应用[J].中草药,2007,38(6):946-948. 被引量:10
  • 4岳鹏飞,游荣辉,杨明,袁海龙,肖小河.葛根素亚微乳的制备及家兔体内药物动力学评价[J].中国医药工业杂志,2007,38(7):491-495. 被引量:4
  • 5Crauste-Manciet S,Brossard D,Decroix MO,et al.Cefpodoxime-proxetil protection from intestinal lumen hydrolysis by oil-in-water submicron emulsions[J].Int J Pharm,1998,165(1):97-106.
  • 6Teixeira H,Dubemet C,Rosilio V,et al.Factors influencing the oligonucleotides release from O-W submicron cationic emulsions[J].J Controlled Release,2001,70 (1-2):243-255.
  • 7MacFie J.The development of fat emulsions[J].Nutrition.1999,15(7-8):643-645.
  • 8Han J,Washington C.Partition of antimicrobial additives in an intravenous emulsion and their effect on emulsion physical stability[J].Int J Pharm,2005,288 (2):263-271.
  • 9Watrobska-Swietlikowska D,Sznitowska M.Partitioning of parabens between phases of submicron emulsions stabilized with egg lecithin[J].Int J Pharm,2006,312 (1-2):174-178.
  • 10Cui F,Shi K,Zhang L,et al.Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery:preparation,in vitro characterization and in vivo evaluation[J].J Controlled Release,2006,114 (2):242-250.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部